Iranian nano-based nail treatment hits market as affordable antifungal solution

A new Iranian-made nano-drug, Amoronic, has entered the domestic market as a powerful and long-lasting treatment for nail fungal infections.

Developed by the knowledge-based company Kimia Kalaye Razi, the product uses advanced nanotechnology to deliver its active ingredient, amorolfine 5%, directly and steadily into the nail.

According to the Vice Presidency for Science, Technology and Knowledge-Based Economy, Amoronic addresses onychomycosis—a common nail fungal infection, especially among diabetics and individuals with weakened immune systems.

Poor footwear and humid conditions further contribute to the infection’s spread.

Thanks to smart micro-polymers, Amoronic overcomes the usual challenge of drug penetration through the tough nail structure. It forms a transparent, water-resistant film that releases medication gradually, enhancing treatment effectiveness while minimizing recurrence. Each package contains a solution bottle, nail file, and applicator.

The treatment protocol involves filing the infected nail, disinfecting it with alcohol, and applying the lacquer. The recommended treatment duration is six months for fingernails and up to twelve months for toenails.

While comparable foreign products cost around $35, Amoronic is offered to Iranian patients at less than one-seventh of that price.

This innovation not only boosts local drug accessibility but also reduces healthcare expenses significantly.